HIV infection and microbial diversity in saliva

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1400-1411

  Li, Yihong ^a   Saxena, Deepak ^a   Chen, Zhou ^a   Liu, Gaoxia ^a,d   Abrams, Willam R ^a   Phelan, Joan A ^a   Norman, Robert G ^a   Fisch, Gene S ^a   Corby, Patricia M ^a   Dewhirst, Floyd ^b,c   Paster, Bruce J ^b,c   Kokaras, Alexis S ^b   Malamud, Daniel ^a  

^a NEW YORK UNIVERSITY   (United States)

^b FORSYTH INSTITUTE   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RNA 16S;

16S RRNA GENE; ACTINOMYCES; ADULT; AGGREGATIBACTER; ARTICLE; ATOPOBIUM; BACTERIUM; CAMPYLOBACTER; CANDIDA; CAPNOCYTOPHAGA; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; FUSOBACTERIUM; GEMELLA; GRANULICATELLA; HAEMOPHILUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN ORAL MICROBE IDENTIFICATION MICROARRAY ASSAY; KINGELLA; LACTOBACILLUS; LEPTOTRICHIA; MALE; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; MICROBIOLOGY; NEISSERIA; NONHUMAN; PARVIMONAS; PEPTOSTREPTOCOCCACEAE; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; RNA FINGERPRINTING; RNA GENE; ROTHIA; SALIVA; SELENOMONAS; SEROPREVALENCE; SLACKIA; SOLOBACTERIUM; STREPTOCOCCUS; STREPTOCOCCUS MUTANS; SYNERGISTETES; VEILLONELLA; VIRUS CULTURE; CLASSIFICATION; GENETICS; HIV INFECTIONS; PROCEDURES; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIA; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; RNA, RIBOSOMAL, 16S; SALIVA;

EID: 84899554300     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02954-13     Document Type: Article

References (78)

1. Joint United Nations Programme on HIV/AIDS. 2013. Global report: UNAIDS report on the global AIDS epidemic 2013. Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.
2. Aberg J, Powderly W. 2010. HIV: primary and secondary prophylaxis for opportunistic infections. Clin. Evid. 2010:0908. http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3217757/pdf/2010-0908.pdf.
3. Greenspan D. 1994. Treatment of oral candidiasis in HIV infection. Oral Surg. Oral Med. Oral Pathol. 78:211-215. http://dx.doi.org/10.1016/0030-4220 (94) 90149-X.
4. Owotade FJ, Shiboski CH, Poole L, Ramstead CA, Malvin K, Hecht FM, Greenspan JS. 2008. Prevalence of oral disease among adults with primary HIV infection. Oral Dis. 14:497-499. http://dx.doi.org/10.1111/j.1601-0825.2007. 01407.x.
5. Boackle RJ. 1991. The interaction of salivary secretions with the human complement system: a model for the study of host defense systems on inflamed mucosal surfaces. Crit. Rev. Oral Biol. Med. 2:355-367.
6. Fidel PLJ. 2011. Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis. Adv. Dent. Res. 23:45-49. http://dx.doi.org/10. 1177/0022034511399284.
7. Owotade FJ, Patel M, Ralephenya TR, Vergotine G. 2013. Oral Candida colonization in HIV-positive women: associated factors and changes following antiretroviral therapy. J. Med. Microbiol. 62:126-132. http://dx.doi.org/10. 1099/jmm.0.047522-0.
8. Ryder MI, Nittayananta W, Coogan M, Greenspan D, Greenspan JS. 2012. Periodontal disease in HIV/AIDS. Periodontol 2000 60:78-97. http://dx.doi.org/ 10.1111/j.1600-0757.2012.00445.x.
9. Sales-Peres SH, Mapengo MA, de Moura-Grec PG, Marsicano JA, Sales-Peres AC. 2012. Oral manifestations in HIV+ children in Mozambique. Cien. Saude Colet. 17:55-60. http://dx.doi.org/10.1590/S1413-81232012000100008.
10. Beena JP. 2011. Prevalence of dental caries and its correlation with the immunologic profile in HIV-infected children on antiretroviral therapy. Eur. J. Paediatr. Dent. 12:87-90.
11. Fine DH, Tofsky N, Nelson EM, Schoen D, Barasch A. 2003. Clinical implications of the oral manifestations of HIV infection in children. Dent. Clin. North Am. 47:159-174, xi-xii. http://dx.doi.org/10.1016/S0011-8532 (02) 00057-5.
12. Ramos MPdA, Ferreira SMS, Silva-Boghossian CM, Souto R, Colombo AP, Noce CW, Goncalves LdS. 2012. Necrotizing periodontal diseases in HIV-infected Brazilian patients: a clinical and microbiologic descriptive study. Quintessence Int. 43:71-82.
13. Umadevi M, Adeyemi O, Patel M, Reichart PA, Robinson PG. 2006. (B2) Periodontal diseases and other bacterial infections. Adv. Dent. Res. 19:139-145. http://dx.doi.org/10.1177/154407370601900125.
14. Fricke U, Geurtsen W, Staufenbiel I, Rahman A. 2012. Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study. Eur. J. Med. Res. 17:2. http://dx.doi.org/10.1186/2047-783X-17-2.
15. Khammissa R, Feller L, Altini M, Fatti P, Lemmer J. 2012. A comparison of chronic periodontitis in HIV-seropositive subjects and the general population in the Ga-Rankuwa Area, South Africa. AIDS Res. Treat. 2012:620962. http://dx.doi.org/10.1155/2012/620962.
16. Liu G, Saxena D, Chen Z, Norman RG, Phelan JA, Laverty M, Fisch GS, Corby PM, Abrams W, Malamud D, Li Y. 2012. HIV infection affects Streptococcus mutans levels, but not genotypes. J. Dent. Res. 91:834-840. http://dx.doi.org/10.1177/ 0022034512454298.
17. Cassone A, Cauda R. 2012. Candida and candidiasis in HIV-infected subjects: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS 26:1457-1472. http://dx.doi.org/10.1097/QAD. 0b013e3283536ba8.
18. Leigh JE, Shetty K, Fidel PLJ. 2004. Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patient Care STDS 18:443-456. http://dx.doi.org/10.1089/108729104170 3665.
19. Greenspan JS, Greenspan D. 2002. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis. 8(Suppl 2):34-39. http://dx.doi.org/10.1034/j.1601-0825.2002.00009.x.
20. Fidel PLJ. 2002. Immunity to Candida. Oral Dis. 8(Suppl 2):69-75. http://dx.doi.org/10.1034/j.1601-0825.2002.00015.x.
21. Leigh JE, Steele C, Wormley FLJ, Luo W, Clark RA, Gallaher W, Fidel PLJ. 1998. Th1/Th2 cytokine expression in saliva of HIV-positive and HIVnegative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:373-380. http://dx.doi.org/10.1097/00042560-199812010-00008.
22. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL. 2000. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 30(Suppl 1):S5-S14. http://dx.doi.org/10.1086/313843.
23. Navazesh M, Mulligan R, Pogoda J, Greenspan D, Alves M, Phelan J, Greenspan J, Slots J. 2005. The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS). Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100:701-708. http://dx.doi.org/10.1016/j.tripleo.2004.10.011.
24. Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikolaou IS, Kordossis T. 2004. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients: a Greek study. Oral Dis. 10:145-150. http://dx.doi.org/10.1046/j.1601-0825.2003.00994.x.
25. Yang YL, Lo HJ, Hung CC, Li Y. 2006. Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMCInfect. Dis. 6:8. http://dx.doi.org/10.1186/1471-2334-6-8.
26. Muyzer G. 1999. DGGE/TGGE a method for identifying genes from natural ecosystems. Curr. Opin. Microbiol. 2:317-322. http://dx.doi.org/10.1016/S1369- 5274 (99) 80055-1.
27. Muyzer G, de Waal EC, Uitterlinden AG. 1993. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59:695-700.
28. Dye BA, Tan S, Smith V, Lewis BG, Barker LK, Thornton-Evans G, Eke PI, Beltran-Aguilar ED, Horowitz AM, Li CH. 2007. Trends in oral health status: United States, 1988-1994 and 1999-2004. Vital Health Stat. 11(248):1-92. http://www.cdc.gov/nchs/data/series/sr-11/sr11-248.pdf.
29. Ramfjord SP. 1959. Indices for prevalence and incidence of periodontal disease. J. Periodontol. 30:51-59.
30. Gold OG, Jordan HV, Van Houte J. 1973. A selective medium for Streptococcus mutans. Arch. Oral Biol. 18:1357-1364. http://dx.doi.org/10.1016/ 0003-9969 (73) 90109-X.
31. Rogosa M, Mitchell JA, Wiseman RF. 1951. A selective medium for the isolation and enumeration of oral lactobacilli. J. Dent. Res. 30:682-689. http://dx.doi.org/10.1177/00220345510300051201.
32. Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, Fiske J, Lewis D, Daly B, Khalifa N, Marren V, Lynch E. 1995. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J. Clin. Microbiol. 33:3025-3027.
33. Odds FC, Bernaerts R. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
34. Liu G, Saxena D, Deng H, Norman RG, Chen Z, Abrams WR, Malamud D, Li Y. 2010. Effect of protease inhibitors on the quantitative and qualitative assessment of oral microorganisms. FEMS Microbiol. Lett. 312:63-70. http://dx.doi.org/10.1111/j.1574-6968.2010.02100.x.
35. Li Y, Ge Y, Saxena D, Caufield PW. 2007. Genetic profiling of the oral microbiota associated with severe early-childhood caries. J. Clin. Microbiol. 45:81-87. http://dx.doi.org/10.1128/JCM.01622-06.
36. Muyzer G, Smalla K. 1998. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie Van Leeuwenhoek 73:127-141. http://dx.doi.org/10. 1023/A:1000669317571.
37. Knapp LA. 2005. Denaturing gradient gel electrophoresis and its use in the detection of major histocompatibility complex polymorphism. Tissue Antigens 65:211-219. http://dx.doi.org/10.1111/j.1399-0039.2005.00368.x.
38. Ferguson AS, Huang WE, Lawson KA, Doherty R, Gibert O, Dickson KW, Whiteley AS, Kulakov LA, Thompson IP, Kalin RM, Larkin MJ. 2007. Microbial analysis of soil and groundwater from a gasworks site and comparison with a sequenced biological reactive barrier remediation process. J. Appl. Microbiol. 102:1227-1238. http://dx.doi.org/10.1111/j.1365-2672.2007.03398.x.
39. Li Y, Ku CY, Xu J, Saxena D, Caufield PW. 2005. Survey of oral microbial diversity using PCR-based denaturing gradient gel electrophoresis. J. Dent. Res. 84:559-564. http://dx.doi.org/10.1177/1544059105084 00614.
40. Li Y, Saxena D, Barnes VM, Trivedi HM, Yao G, Xu T. 2006. Polymerase chain reaction-based denaturing gradient gel electrophoresis in the evaluation of oral microbiota. Oral Microbiol. Immunol. 21:333-339. http://dx.doi.org/10. 1111/j.1399-302X.2006.00301.x.
41. Li Y, Ismail AI, Ge Y, Tellez M, Sohn W. 2007. Similarity of bacterial populations in saliva from African-American mother-child dyads. J. Clin. Microbiol. 45:3082-3085. http://dx.doi.org/10.1128/JCM.00771-07.
42. Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D. 2012. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 18:85-95. http://dx.doi.org/10.1111/j.1601-0825.2011.01848.x.
43. Lane DJ. 1991. 16S/23S rRNA sequencing, p 115-147. In Stackebrandt E, Goodfellow M (ed), Nucleic acid techniques in bacterial systematics. John Wiley & Sons, New York, NY.
44. Rupf S, Merte K, Eschrich K. 1999. Quantification of bacteria in oral samples by competitive polymerase chain reaction. J. Dent. Res. 78:850-856. http://dx.doi.org/10.1177/00220345990780040501.
45. Sheffield VC, Cox DR, Lerman LS, Myers RM. 1989. Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc. Natl. Acad. Sci. U. S. A. 86:232-236. http://dx.doi.org/10.1073/pnas.86.1. 232.
46. Colombo AP, Boches SK, Cotton SL, Goodson JM, Kent R, Haffajee AD, Socransky SS, Hasturk H, Van Dyke TE, Dewhirst F, Paster BJ. 2009. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J. Periodontol. 80:1421-1432. http://dx.doi.org/10. 1902/jop. 2009.090185.
47. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. 2003. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378.
48. Ward JHJ. 1963. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58:236-244. http://dx.doi.org/10.1080/01621459.1963. 10500845.
49. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:14863-14868. http://dx.doi.org/10.1073/pnas.95.25.14863.
50. Holm S. 1979. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6:65-70.
51. + cell counts during potent antiretroviral therapy in HIV patients. J. Antimicrob. Chemother. 53:494-500. http://dx.doi.org/10.1093/jac/dkh105.
52. + T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin. Microbiol. Infect. 18:449-458. http://dx.doi.org/10.1111/j.1469- 0691.2011.03650.x.
53. Izadi N, Goetz MB, Graber CJ. 2012. Inverse correlation of initial CD8 lymphocyte count and CD4 lymphocyte response to combination antiretroviral therapy in treatment-naive HIV-infected patients. J. Acquir. Immune Defic. Syndr. 59:e1-e3. http://dx.doi.org/10.1097/QAI.0b013e3182 3d3277.
54. + cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy. J. Clin. Immunol. 29:311-318. http://dx.doi.org/10.1007/s10875-009- 9275-y.
55. Zijenah LS, Katzenstein DA, Nathoo KJ, Rusakaniko S, Tobaiwa O, Gwanzura C, Bikoue A, Nhembe M, Matibe P, Janossy G. 2005. T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years. J. Transl. Med. 3:6. http://dx.doi.org/10.1186/1479-5876-3-6.
56. + T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25:2123-2131. http://dx.doi.org/10.1097/QAD.0b013e32834c4ac1.
57. Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Klein MB. 2013. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One 8:e77665. http://dx.doi.org/10.1371/journal. pone.0077665.
58. Fellay J, Boubaker K, Ledergerber B, Bernasconi E, Furrer H, Battegay M, Hirschel B, Vernazza P, Francioli P, Greub G, Flepp M, Telenti A. 2001. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 358:1322-1327. http://dx.doi.org/10.1016/S0140- 6736 (01) 06413-3.
59. Spear GT, Sikaroodi M, Zariffard MR, Landay AL, French AL, Gillevet PM. 2008. Comparison of the diversity of the vaginal microbiota in HIVinfected and HIV-uninfected women with or without bacterial vaginosis. J. Infect. Dis. 198:1131-1140. http://dx.doi.org/10.1086/591942.
60. Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, Sogin ML, Morrison HG, Paster BJ, O'Toole GA. 2012. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J. Bacteriol. 194:4709-4717. http://dx.doi.org/10.1128/JB.00566-12.
61. Docktor MJ, Paster BJ, Abramowicz S, Ingram J, Wang YE, Correll M, Jiang H, Cotton SL, Kokaras AS, Bousvaros A. 2012. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 18:935-942. http://dx.doi.org/10.1002/ibd.21874.
62. Paster BJ, Russell MK, Alpagot T, Lee AM, Boches SK, Galvin JL, Dewhirst FE. 2002. Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects. Ann. Periodontol. 7:8-16. http://dx.doi.org/10.1902/ annals.2002.7.1.8.
63. Marsh P, Martin M. 1999. Acquisition, adherence, distribution and metabolism of the oral microflora, p 34-57. In Marsh P, Martin M (ed), Oral microbiology, 4th ed. Reed Educational and Professional Publishing Ltd., Bodmin, Cornwall, United Kingdom.
64. Liljemark WF, Gibbons RJ. 1971. Ability of Veillonella and Neisseria species to attach to oral surfaces and their proportions present indigenously. Infect. Immun. 4:264-268.
65. You M, Mo S, Watt RM, Leung WK. 2013. Prevalence and diversity of Synergistetes taxa in periodontal health and disease. J. Periodontal Res. 48:159-168. http://dx.doi.org/10.1111/j.1600-0765.2012.01516.x.
66. Belibasakis GN, Ozturk VO, Emingil G, Bostanci N. 2013. Synergistetes cluster A in saliva is associated with periodontitis. J. Periodontal Res. 48:727-732. http://dx.doi.org/10.1111/jre.12061.
67. Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, Yang ZK, Podar M, Leys EJ. 2012. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 6:1176-1185. http://dx.doi.org/10.1038/ismej.2011.191.
68. Feikin DR, Feldman C, Schuchat A, Janoff EN. 2004. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect. Dis. 4:445-455. http://dx.doi.org/10.1016/S1473-3099 (04) 01060-6.
69. Dang AT, Cotton S, Sankaran-Walters S, Li CS, Lee CY, Dandekar S, Paster BJ, George MD. 2012. Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients. BMC Microbiol. 12:153. http://dx.doi.org/10.1186/1471-2180-12-153.
70. Aas JA, Barbuto SM, Alpagot T, Olsen I, Dewhirst FE, Paster BJ. 2007. Subgingival plaque microbiota in HIV positive patients. J. Clin. Periodontol. 34:189-195. http://dx.doi.org/10.1111/j.1600-051X.2006.01034.x.
71. Baqui A, Meiller T, Jabra-Rizk M, Zhang M, Kelley J, Falkler W. 1999. Association of HIV viral load with oral diseases. Oral Dis. 5:294-298.
72. Patel M, Coogan M, Galpin JS. 2003. Periodontal pathogens in subgingival plaque of HIV-positive subjects with chronic periodontitis. Oral Microbiol. Immunol. 18:199-201. http://dx.doi.org/10.1034/j.1399-302X.2003.00064.x.
73. Goncalves LS, Soares Ferreira SM, Souza CO, Souto R, Colombo AP. 2007. Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositive Brazilians undergoing highly active antiretroviral therapy and HIV-seronegative Brazilians with chronic periodontitis. J. Periodontol. 78:87-96. http://dx.doi.org/10.1902/jop. 2007.060040.
74. Johnson NW. 1997. Essential questions concerning periodontal diseases in HIV infection. Oral Dis. 3(Suppl 1):S138-S140. http://dx.doi.org/10.1111/j.1601- 0825.1997.tb00347.x.
75. Lin AL, Johnson DA, Sims CA, Stephan KT, Yeh CK. 2006. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART). Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102:318-324. http://dx.doi.org/10.1016/j.tripleo.2005.07.021.
76. Phelan JA, Mulligan R, Nelson E, Brunelle J, Alves ME, Navazesh M, Greenspan D. 2004. Dental caries in HIV-seropositive women. J. Dent. Res. 83:869-873. http://dx.doi.org/10.1177/154405910408301109.
77. + T cell counts in HIV-positive patients. Int. J. Dent. 2012:157641. http://dx.doi.org/10.1155/ 2012/157641.
78. Ellis CL, Ma ZM, Mann SK, Li CS, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM. 2011. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomalDNA (rDNA) quantification and correlations with immune activation. J. Acquir. Immune Defic. Syndr. 57:363-370. http://dx.doi.org/10.1097/QAI. 0b013e31821a603c.